Giant cell glioblastoma is associated with altered aurora b expression and concomitant p53 mutation were found, however its mRNA levels and protein levels were significantly higher in gcGB than in GB. 59% of gcGB, but only 18% of the matched GB samples showed p53 mutations. Ectopic overexpression of Aurora B induced a significant increase in the proportion of multinucleated cells in U373-MG (p53 mutant) but not in U87-MG (p53 wild-type) cells. In addition, RNAi of p53 in U87-MG led to an increase in the fraction of multinucleated cells which was further augmented by ectopic overexpression of Aurora B. We suggest that loss of p53 function and deregulated Aurora B protein levels might represent essential factors driving the development of multinuclear cells in gcGB.
Giant cell glioblastoma is associated with altered

Introduction
Giant cell glioblastoma (gcGB) is a rare variant of glioblastoma characterized by a predominance of large, multinucleated giant cells (1) . GcGB accounts for less than 1% of all brain tumors and approximately 5% of all glioblastomas (2;3). Although the prognosis is usually poor, some reports suggested that this glioblastoma variant is associated with a more favorable prognosis than classic glioblastoma (GB) (3) (4) (5) (6) .
The genetic and molecular events leading to the phenotype of gcGB cells have remained largely uncertain. Because of the appearance of huge cells displaying enormous nuclei or multiple nuclei, defects in late mitosis may be responsible for this particular phenotype. It is anticipated that members of mitotic kinases such as pololike kinase and Aurora-like kinases are associated with disturbed chromosomal segregation and defective or incomplete cytokinesis in cancer cells (7) . Indeed, a previous report indicated that gcGB specimens and especially the fraction of multinucleated giant cells had a non-functional Aurora B kinase (8) . Aurora B is a serine/threonine kinase belonging to the family of mitotic Aurora kinases which are evolutionary conserved from yeast to human (9) . Overexpression of Aurora B mRNA and protein are frequently detected in human cancer cells (10) (11) (12) . During the onset of mitosis Aurora B kinase is maximally expressed and forms, with its molecular partners inner centromeric proteins (INCENP), survivin, and borealin, the chromosomal passenger complex (CPP) (for review see (13)). Within the passenger complex, Aurora B provides kinase activity toward multiple proteins involved in chromosomal segregation and cytokinesis. Aurora B modifies chromatin by phosphorylation of centromere protein A (CENP-A) (14) and histone H3 (15) and thus contributes to the process of chromatin condensation and kinetochore maturation. In addition, Aurora B is involved at the spindle checkpoint and regulates cytokinesis by phosphorylating target proteins in the cleavage furrow such as vimentin (16) , desmin (17) , and MgcRacGAP (18) .
Only within the CPP Aurora B is phosphorylated at Thr-232 by an autophosphorylation mechanism, which is indispensable for Aurora-B kinase activity (19) . Therefore, inactivation of one of the components of the CPP by siRNA or the ectopic overexpression of mutant forms of CPP proteins leads to a defective spindle checkpoint resulting in disturbed chromosomal segregation and incomplete cytokinesis (9;20-23) .
GcGB have a higher frequency of p53 mutations and have a lower frequency of EGFR amplifications than GB (3;5;24;25) . P53 is a key player in the regulation of the cell cycle and induction of apoptosis, by transcriptional activation of inhibitors of cyclin dependent kinases, such as p21 waf/cip and by transcriptional activation of proapoptotic genes such as PUMA, Bax or Bad (26) (27) (28) . However, in the setting of gcGB, p53 deficiency may allow that Aurora B dysfunction induces the development of multinucleated giant cells. In addition, a recent report revealed that the small chemical compound VX680, which blocks Aurora kinases, led to a significant increased endoreplication in p53-deficient cells when compared to cells having intact p53 function (29) . We hypothesized that cells with aberrant Aurora B function, due to the loss of functional p53, likely cannot arrest the cell cycle and repetitively undergo multiple rounds of genome replication without completion of cytokinesis.
In the current study, we investigated whether the appearance of multinucleated cells in gcGB is caused by mutations in the Aurora B gene or associated with altered Aurora B expression levels, and concomitant mutations in the tumor suppressor protein p53. We here provide evidence that the phenotype of gcGB is linked to a 
Cell lines
U373-MG is a glioblastoma/astrocytoma-derived cell line, U87-MG, is a glioblastoma-derived cell line. U87-MG contains wild-type p53, (30) the U373 cell line expresses mutant p53 (31) . The cells were cultured in Basal Minimal Eagle medium (BME, Invitrogen, Karlsruhe, Germany) supplemented with 2 mM Lglutamine and 1% non-essential amino acids (Biochrom, Berlin, Germany). 293T are human embryonic kidney cells. They were cultured in Dulbecco´s modified Eagle medium containing 4.5 g/l glucose (PAA Laboratories, Pasching, Austria). The medium was supplemented with 10% heat inactivated fetal calf serum, 100 U/ml penicillin and 100 µg/ml streptomycin (Invitrogen).
Analysis of genomic p53 and Aurora B mutations
Mutational analysis of the coding regions of p53 known to contain the DNA-binding domain and the hot spot mutation sites (32) (exons 5-9; for primer sequences see supplementary material) was performed after amplification of exons 5, 6, 7 and 8/9
using (synthesized by Eurofins MWG Operon, Ebersberg, Germany) an amplification protocol described elsewhere (33) . In addition, exons 2-9 of Aurora B, representing the ATP-binding domain and the kinase domain were analyzed using the primers ) per capillary using a pEGFP-Actin vector (Takara-Clontech, Heidelberg, Germany) and plasmids encoding aurora B and survivin, respectively, and were used to calculate the amplification products. All measurements were performed with aliquots from the same cDNA batches to guarantee standardized and comparable conditions. A negative control (no template) was included in each of the PCR runs. The cDNA copy numbers of aurora B and survivin mRNAs were normalized to the quantitative measurements of β-actin mRNA levels. All PCR runs were repeated twice or threefold to ensure reproducibility and reliability and were determined by the Light
Cycler quantification software version 3.5 (Roche).
Histology and immunohistochemistry
Five µm thick serial sections from paraffin-embedded tissues and tissue arrays were cut and processed for staining with hematoxylin-eosin (H&E), and for immunohistochemistry, which was performed using the indirect avidin-biotin- 
Transduction of retroviral vectors
The retroviral vector pcz-CFG5.1-EGFP encoding EGFP has been described previously (34) . A retroviral vector encoding a functional EGFP-Aurora B fusion protein was constructed by introducing a BamHI / BglII-fragment encoding the full coding sequence of Aurora B into the BamHI-site of the vector pcz-CFG2-fEGFPf (22) . For the transduction of DNA-sequences encoding shRNA-molecules we used the self inactivating retroviral Moloney murine leukemia virus backbone pRVH-1-puro. This vector contains a H1 polymerase III promoter for the expression of shRNA molecules in reverse orientation. We utilized the sh53 small hairpin RNA sequence described previously (35) . The upper DNA strand: (5'-gatccccgactccagtggtaatctact tcaagagagtagattaccactggagtctttttggc-3´) and bottom DNA strand (5´-tcgagccaaaaag actccagtggtaatctactctcttgaagtagattaccactggagtcggg-3´) were synthesized by (Eurofins MWG Biotech) annealed and ligated into the BglII / SalI-restrictions sites of pRVH-N1-puro generating pRVH-1-shP53-puro and pRVH-1-shLuc-puro. As control we included a small hairpin RNA targeting luciferase (36) . Retroviral particles were generated as described previously (22) . Briefly, 293T cells were cotransfected with an expression construct for gag-pol (pHIT60) (37), the MoMuLV-based retroviral vectors and the vesicular stomatitis virus G-protein (pMD.G2, kindly provided by D.
Trono, University of Geneva, Switzerland). Viral supernatants were harvested 48 and 72 h after transfection. 10 5 target cells were plated in 30 mm dishes a day before transduction and were transduced with retroviral supernatants at a multiplicity of infection (MOI) of 20. Cells transduced with pRVh-1-shLuc-puro and pRVh-1-shp53-puro were selected for 48h using cell culture medium containing 10µg/ml puromycin (Takara Clontech).
Western Blot analysis
Cells grown in 6 well-plates were harvested in 120 µl 2x Laemmli-protein-samplebuffer (Sigma, Taufkirchen, Germany). Samples were subsequently cooked for 5 min and placed in an ultrasonic bath for 15 min. Equal amounts of protein lysates were separated in 10% polyacrylamide gels. The Proteins were blotted semidry from the gels onto PVDF membranes, which were subsequently blocked over night in TBS buffer + 5% milk powder. Then membranes were washed 3 times for 10 min in TBS + 2% Triton X-100, 0.5% Tween 20 and another 10 min in TBS. The membranes were incubated with anti-Aurora B (rabbit polyclonal; 1:1000; Sigma), anti p53 (goat polyclonal; 1:1000; R&D Systems, Wiesbaden, Germany) or anti α-tubulin (mouse monoclonal; 1:5000; Sigma). After incubation with the primary antibody the membranes were washed 3 x with TBS-TT and 1 x 10min with TBS-buffer.
Subsequently the membranes were incubated for 1 hour with appropriate species specific secondary antibodies conjugated to HRP (1:1000; Dako, Glostrup, Denmark). The membranes were washed again and imaged with ECL-detection solution (GE Healthcare, Freiburg, Germany) in a LAS3000 device.
Investigating multinuclear cells and DNA analysis
Analysis of polyploidy was determined by flow cytometry using propidium iodidestained cells. Briefly, the cells were washed in PBS and fixed in 70% (v/v) ethanol.
After centrifugation of the cell at 600 g at 20°C for 10 min, the pellet was suspended in 0.5 ml DNA extraction buffer (4 mM citric acid in 0.2 M Na 2 HPO 4 ; pH 7.8). After 5 min incubation at room temperature the cells were spun down at 600 g. The cells
were then washed once with PBS, followed by incubation in PBS containing 40 µg/ml propidium iodide (Sigma) and 200 µg/ml RNase A (Sigma) for 1 h at room temperature in the dark. Stained nuclei were then analyzed using a Becton Dickinson FACScan using cell quest software (BD, Heidelberg, Germany) with at least 10,000 events / determination. Statistical analysis was performed with Student´s t-test. No significant difference was found in the levels of Survivin mRNA expression in gcGB when compared to GB. However, we noted a significant 5-fold increase in Aurora B mRNA copy numbers in gcGB relative to GB (see Fig. 1 ).
Increased expression of Aurora B protein in giant cell glioblastoma
In order to get an overview of Aurora B expression and its subcellular localization in Fig. 2A, G) . Anaplastic gliomas of WHO grade III showed higher numbers of nuclear staining (mean 1.74 %) and slight cytoplasmic staining in some cases (Fig. 2B, G) . A significant increase (p<0.01) in Aurora B signals was observed in classic GB WHO IV (mean 4.71%) when compared to gliomas of WHO grades I-III (Fig. 2C, G) . However, there was a further significant increase of Aurora B immunoreactivity in gcGB (mean 11.98%, p< 0.001) when compared to classic GB ( Fig. 2D-F, G) . Here, two distinct populations were observed: one population of frequently multinucleated giant cells with high nuclear levels of Aurora B and some cytoplasmic staining (Fig. 2E) and a second population of smaller cells resembling tumor cells in classic GB (Fig. 2F ). Quantitative analysis of the fraction of cells with nuclei positive for Aurora B staining of gliomas of varying malignancy revealed that an increase of nuclear Aurora B expression correlated with the WHO grade. However, gcGB samples displayed significantly more Aurora B positive nuclei and also more cytoplasmic Aurora B-staining than all other gliomas of grades WHO grades I-IV (Fig. 2G) .
Some gcGB cells were detected that displayed condensed chromosomes heavily stained for Aurora B (see Fig. 2E ) suggesting a correct function of Aurora B in the early phases of mitosis. This notion was supported when phospho-232T Aurora B was detected in the nuclei of both, giant cell glioblastoma (3A, B) and classic GB (Fig. 3C, D) .
The immunohistochemical assessment of p53 expression revealed a moderate to strong nuclear staining in 28 % of classic GB and in 75 % of gcGB, thus showing a significant difference between these groups (p< 0.001), which is in line with the results obtained by the p53 mutational analysis. In gcGB, nuclear p53-IR appeared more frequently in giant cells and in the population of cells with large pleomorphic nuclei as compared to the cells with small more regularly shaped nuclei (Fig. 3 E, F) .
P53-deficient glioma cells develop a giant cell GB-like phenotype upon ectopic expression of Aurora B
In order to functionally elucidate the p53-Aurora B connection, we transduced glioma cell lines with retroviral vectors encoding EGFP-Aurora B or EGFP, respectively. We used the EGFP-Aurora B fusion gene because it allowed the measurement of transduction efficiencies, could be used to immediately identify the subcellular localization during mitosis, and enhanced the analysis of polyploidy. The transduction efficiencies of U87-MG and U373-MG cells routinely were in the range of 85% to 99% (Fig. 4A) . Transduced EGFP-Aurora B was mostly nuclear in interphase and was localized the kinetochors in metaphase, at the cleavage furrow in anaphase (see Fig. 4C ) and in the midbody in late telophase. Five days after transduction of Aurora B, the p53-deficient U373-MG glioma cells increased in size and acquired multiple nuclei (Fig. 4B, D) . However, some U373 giant cells displayed multiple cleavage furrows (see Fig. 4C ) and multiple midbodies (data not shown) suggesting that they were able to occasionally resolve polyploidy by creating multiple daughter cells (Fig. 4C) . In contrast U87-MG cells containing wild-type p53 showed neither an altered morphology nor an increase in the number of nuclei (Fig. 4D) . As (Fig. 5A, C) .
However, only a moderate but significant increase in polyploidy was noted 72 h after transduction of EGFP-Aurora B in U87-MG glioma cells containing wild type p53 (Fig. 5B, C) . Yet, the transduction of the control vector encoding EGFP had no effect on the cell cycle and the genomic DNA content. Interestingly, overexpression of EGFP-Aurora B led to a significant increase in the fraction of apoptotic cells in both cell lines when compared to the control cells expressing only EGFP (Fig. 5 A, B ).
To further verify the impact of p53 loss of function and Aurora B overexpression on glioma cells we generated U87-MG with stable expression of a provirus encoding a small hairpin RNA targeting p53. As control we included cells transduced with a control vector encoding a small hairpin RNA targeting luciferase (Fig. 6A) . The silencing of p53 led to a significant increase in the fraction of cells bearing a DNA content >4N, when compared to shLuc transduced control cells. A subsequent transduction of EGFP-Aurora B further significantly augmented the development of multinucleated cells in p53-depleted cells whereas no such effect was observed in control cells expressing p53 wild type protein (Fig. 6B) .
Discussion
The mitotic Aurora B kinase has been reported as being highly expressed in various types of transformed cells (10) (11) (12) . In glioblastoma an increase in Aurora B expression has been associated with a shorter survival (38) . Our immunohistochemical analysis of Aurora B in various grades of astrocytic glioma also revealed that the level of expression increased with malignancy. However, strongest expression of Aurora B was noted in gcGB, which recently has been reported to be associated with a better clinical outcome when compared to patients suffering from classic GB (39) . It has been reported that GcGB has a less infiltrative growth pattern than classic GB (40;41). Thus depending on the individual case gcGB often has been described intraoperatively as having a confined demarcation and firmness which makes a gross-total resection of the tumor more amendable which is relevant for the outcome (3;42). Another report indicated a dysfunction of Aurora B kinase in the early mitotic phase and in cytokinesis in giant cell glioblastoma (8) which should lead to decreased proliferation, and therefore might give an explanation on the molecular level for the better prognosis in gcGB patients. Fujita et al. investigated the site-specific phosphorylation of Aurora B substrates in gcGB specimens, in particular histon H3 (Ser28) phosphorylated in prophase (15) , and vimentin (Ser72) phosphorylated in cytokinesis (16) . Although gcGB cells expressed Aurora B and enter early mitosis, P-Ser-28-histon H3 and P-Ser72-vimentin immmunosignals were not detected in giant cell glioblastoma cells. Therefore, the authors suggested that Aurora B kinase function was absent in gcGB. However, the mechanism leading to the inactivation of Aurora B function, i.e. caused by mutations in the ATP-binding domain or of the kinase domain, was not investigated. To address this point, we directly sequenced exons 2-9 of the Aurora B gene in 17 giant cell glioblastoma samples. However, no mutations were detected.
The majority of the gcGB samples had mutations in the p53 gene. This observation and the immunohistological analysis of p53 staining are in line with previous studies showing a higher incidence of p53 mutations in gcGB when compared to other primary glioblastomas (3;5).
Next, we found that gcGB expressed significantly more Aurora B kinase mRNA and protein than classic GB. In contrast, no significant differences in mRNA expression levels of Survivin were noted. The immunohistochemical analyses revealed that more nuclei contained Aurora B immunosignals in gcGB samples when compared to classic GB. Furthermore, the Aurora B immunosignals were most prominent in the nuclei of the multinucleated giant cells. An additional Aurora B staining was noted in the cytosol. Giant cells bearing heavily condensed chromosomes and strong Aurora B immunosignals were frequently observed, which confirms that the gcGB cells were able to enter prometaphase. Furthermore, phospho-232T Aurora B kinase was detected in nuclei of giant cell glioblastoma cells, indicative of activated Aurora B.
These observations contrast the recent report from Fujiita et al. (8) . These authors reported an early mitotic arrest of multinuclear U251-MG cells, which was accompanied by lack of Aurora B-mediated histon H3 phosphorylation and chromosome condensation, respectively. We cannot explain these differences;
however, we assume that caution is advised when comparing the phenotypes of permanent glioma cell lines and giant cell glioblastoma in vivo. We assume that both overexpression and down-modulation of Aurora B activity may lead to similar phenotypes and that a fine regulation during the cell cycle is necessary for normal Aurora B function. In fact, a recent report demonstrates that silencing of Aurora B in p53-deficient cells induces polyploidy (21) .
The observation that the protein levels of Aurora B were significantly increased in cells of gcGB when compared to classic GB raises the question of how a deregulated intracellular Aurora B concentration leads to a multinuclear phenotype.
We hypothesized that this is likely due to a disturbed stoichometry of the CPP GB. Copy numbers of Survivin and Aurora B transcripts were normalized to β-actin mRNA copy numbers. In total 17 gcGB samples and 22 sex and age matched GB controls were analyzed. Note that the Aurora B expression was significantly higher in gcGB. Survivin mRNA levels were also high in gcGB, however, the difference was not significant. *p>0.05 when using Student´s t-test. 100µm; for E and F: 50µm. All sections were counterstained with hematoxylin. G:
Quantitative analysis of Aurora B expression in gliomas of different WHO grades.
gcGB were compared to GB WHO grade IV *p<0.001 when using Student´s t-test. 
